Trupanion (TRUP) Stock Overview
Provides medical insurance for cats and dogs on subscription basis in the United States, Canada, Continental Europe, and Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
TRUP Community Fair Values
See what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Trupanion, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$26.36 |
| 52 Week High | US$57.89 |
| 52 Week Low | US$23.80 |
| Beta | 1.49 |
| 1 Month Change | 2.77% |
| 3 Month Change | -16.50% |
| 1 Year Change | -41.17% |
| 3 Year Change | 3.17% |
| 5 Year Change | -65.04% |
| Change since IPO | 131.23% |
Recent News & Updates
TRUP: Clustered Price Cuts And P/E Reset Will Shape Future Returns
Trupanion's updated analyst price target has been reduced by a mid single digit dollar amount, with analysts pointing to recently lowered targets from several firms, alongside only modest tweaks to long term revenue growth, profit margin and future P/E assumptions. Analyst Commentary Recent Street research on Trupanion has centered on a series of price target reductions, with cuts ranging from low single digit dollar amounts up to a $15 move.TRUP: Revised P/E And Margin Assumptions Will Support Future Earnings Power
Trupanion's updated analyst price target has shifted from $42.00 to $31.00 as analysts factor in different assumptions for future revenue growth, profitability and P/E expectations following several recent target cuts across the Street. Analyst Commentary Recent Street research on Trupanion has centered on a series of lower price targets, with several bearish analysts trimming their expectations within a relatively short time frame.TRUP: Rebased P/E Expectations Will Support Long Term Upside Potential
Narrative Update on Trupanion The analyst price target for Trupanion has been reduced by a combined $26, as several firms revisited their models and pricing assumptions. This led to a lower implied future P/E while keeping the fair value estimate steady at $46.25.TRUP: Reset Expectations And Higher Future P/E Will Drive Long-Term Repricing
Trupanion's updated $63.0 analyst price target reflects modestly tempered expectations for revenue growth and profit margin, with analysts citing recent target reductions from several firms as they reassess the stock's risk and return trade off. Analyst Commentary Recent Street research on Trupanion clusters around lower price targets, but the tone is not uniformly negative.Recent updates
Shareholder Returns
| TRUP | US Insurance | US Market | |
|---|---|---|---|
| 7D | -3.3% | -1.7% | 0.6% |
| 1Y | -41.2% | -8.5% | 28.4% |
Return vs Industry: TRUP underperformed the US Insurance industry which returned -8.1% over the past year.
Return vs Market: TRUP underperformed the US Market which returned 28.2% over the past year.
Price Volatility
| TRUP volatility | |
|---|---|
| TRUP Average Weekly Movement | 7.6% |
| Insurance Industry Average Movement | 4.4% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: TRUP has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: TRUP's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 1,121 | Margi Tooth | www.trupanion.com |
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Trupanion, Inc. Fundamentals Summary
| TRUP fundamental statistics | |
|---|---|
| Market cap | US$1.06b |
| Earnings (TTM) | US$25.80m |
| Revenue (TTM) | US$1.48b |
Is TRUP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TRUP income statement (TTM) | |
|---|---|
| Revenue | US$1.48b |
| Cost of Revenue | US$1.15b |
| Gross Profit | US$330.92m |
| Other Expenses | US$305.12m |
| Earnings | US$25.80m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.59 |
| Gross Margin | 22.34% |
| Net Profit Margin | 1.74% |
| Debt/Equity Ratio | 27.7% |
How did TRUP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/04 13:20 |
| End of Day Share Price | 2026/05/04 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Trupanion, Inc. is covered by 15 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christopher Merwin | Barclays |
| Joshua Shanker | BofA Global Research |
| Ryan Tunis | Cantor Fitzgerald & Co. |